The Clinical Research Of Jinkuishenqi Decoction In The Treatment Of Chronic Obstructive Pulmonary Disease Patients In Plateau Period With Kidney Yang Deficiency Type

ObjectiveClinical observation of the subject by the addition and subtraction of Jinkuishenqiwan deficiency Treatment of chronic obstructive pulmonary disease, is a traditional Chinese medicine treatment of this disease to explore new ideas, so that more patients benefit from it.MethodsFollow the principles of evidence-based medicine and controlled trials, clinical studies using statistical methods disease from June2013to February2014related to the recruitment of volunteers met the diagnostic criteria in the Guangdong Provincial Hospital outpatient department, in accordance with strict criteria to be included chronic obstructive pulmonary disease in accordance with the principles of randomized controlled divided into Western medicine control group (placebo orally mucosolvan+particles), the combination therapy group (Jinkuishenqiwan plus or minus side:yellow, yam, dogwood (wine Sunburn), Poria, moutan, Alisma, Gui, monkshood (Sunburn), hyssop (to the head), Plantago (salt Sunburn) subtraction+WM group plan),14d for a course, the next course of treatment interval3d. Intended for a period of two months, the follow-up period. Comparison of patients before and after treatment of cough, sputum, wheezing, pulmonary function tests (FEV1/FVC, RV/TLC), changes in blood gas analysis, while the two groups of patients included in the clinical treatment carried out basic information, follow-up of efficacy and fill survey questionnaire to complete the investigation into the object-related. Investigation and Research to establish a database comparison, using descriptive statistics, control and other methods of data analysis, analysis of the efficacy Jinkuishenqiwan plus or minus side of the treatment of this diseaseResultsCompared with before treatment after treatment in the treatment group, groups, FEV1and other indicators are significant rise, with statistically significant difference (P<0.05). FEV1before and after treatment in the control group showed no significant changes in other indicators (P>0.05). Compared with before treatment after treatment in the treatment group, group, FEV1/FVC and other indicators are significant rise, with statistically significant difference (P<0.05). FEV1/FVC before and after treatment in the control group showed no significant changes in other indicators (P>0.05). TCM syndrome score, the two groups before treatment, the symptom score was no significant difference (P>0.05); After treatment, the treatment group than the control group TCM syndrome score is low, and a statistically significant (P<0.05). Efficacy in disease control group,39cases, clinical cure0cases (0.00%), effective in3cases (7.69%),5cases (12.82%), ineffective in31cases (79.49%), the total efficiency of20.51%.38cases of treatment group, clinical cure one case (2.63%), effective in6cases (15.79%), effective in13cases (33.33%), ineffective in18cases (46.15%), the total efficiency of53.85%. There are always two groups after the treatment efficiency between groups, were statistically significant (P<0.05).ConclusionJinkuishenqiwan plus or minus side for the treatment of chronic obstructive pulmonary disease deficiency effective...